M&A: Bioventus Inc.

Form Type: 8-K

Filing Date: 2025-01-03

Corporate Action: Acquisition

Type: New

Accession Number: 000162828025000253

Comments: On December 31, 2024, Bioventus Inc. completed an acquisition involving its subsidiary Bioventus LLC, which sold all issued and outstanding shares of Bioness Neuromodulation Ltd. to Rehab Acquisition Corporation III (now known as Bioness Medical, Inc.). The Sellers received $25 million in cash, subject to post-closing adjustments, and may receive up to $20 million in earn-out payments based on specified revenue and EBITDA targets over the next two fiscal years (2025 and 2026). This acquisition was previously disclosed in a Current Report filed on October 4, 2024, detailing the terms and conditions of the Purchase Agreement. A press release regarding the closing of this transaction was issued on January 2, 2025, and is attached as an exhibit to the current filing.

Document Link: View Document